James Gartner of CareSource and Jessica Frank of OutcomesMTM shared the first-year results of a cooperative comprehensive medication therapy management (MTM) program that they implemented for nearly 1 million Ohio Medicaid members.
James Gartner of CareSource and Jessica Frank of OutcomesMTM shared the first-year results of a cooperative comprehensive medication therapy management (MTM) program that they implemented for nearly 1 million Ohio Medicaid members. As one of the country’s biggest Medicaid managed healthcare plans, CareSource provides consistency across MTM programs, including networking requirements, covered services policies and procedures, quality assurance, and documentation standards and reporting. OutcomesMTM leverages local relationships with pharmacists, patients, and prescribers while using innovative technology.
Through further detailed analysis, Drs Gartner and Frank presented findings showing how the MTM is working to improve the health of Ohio Medicaid beneficiaries. Dr Frank specifically highlighted that the OutcomesMTM network performance team is “dedicated to providing support, encouragement, and resources pharmacists need to operationalize MTM locally within a community.”
Before the CareSource Ohio program launch in 2012, 400 pharmacies participated. By the end of 2013, that number had more than tripled to 1500 participating pharmacies. Year 1 results also demonstrated that of 106,239 MTM services delivered, 40% were associated with adherence. Most issues related to adherence involved misuse and how patients were administering medications.
Dr Gartner said that in an internal analysis of the Year 1 results, CareSource discovered a return on investment of $4.4 to $1. He reported he was “happy with the results.”
Both presenters said the case findings are promising. These include the following:
Based on the results of this case, MTM has demonstrated a positive ROI for managed Medicaid. As for future actions of the program, Drs Gartner and Frank say they want to enhance coordination of care by “building a bridge between MTM program and case management” as well as learning how to leverage local pharmacist relationships more effectively.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More